Biotechnology Stocks I Performance Guide: Crinetics Pharmaceuticals, Inc. (CRNX)
CRNX has no dividends.
Table and Chart of CRNX Performance
See what a $1,000 investment in CRNX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CRNX Returns | |
|---|---|
| Start Date | Aug-31-2018 |
| Start Price | $29.99 |
| End Date | Oct-11-2024 |
| End Price | $53.14 |
| # Prices | 75 |
| Min Date | Oct-30-2020 |
| Min Price | $12.08 |
| Max Date | Oct-11-2024 |
| Max Price | $53.14 |
| Total Return | 77.19% |
| Annualized Return | 9.59% |
| Current Value of $1,000 Purchase | $1,772 |
| Number Returns | 2,775 |
| Average Return | 36.11% |
| Number Profitable Returns | 1,691 |
| Percent Profitable Returns | 60.94% |
| Number Unprofitable Returns | 1,084 |
| Percent Unprofitable Returns | 39.06% |
| Profitable to Unprofitable Returns Ratio | 1.56 |
| CRNX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -13.400 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -276184992 |
| PE to Growth Ratio | None |
| Price to Book | 3454.51 |
| PRICE DATA | |
| 52 Week High | $0.636 |
| 52 Week Low | $55.78 |
| Analyst Target Price | $-0.596 |
| 50-Day Moving Average | $25.75 |
| 200-Day Moving Average | $51.83 |
| FINANCIAL DATA | |
| Revenue per Share | $-3.76 |
| Revenue | $0 |
| Profit Margin | 2% |
| Return on Equity | -28.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CRNX Compare Returns with S&P 500
CRNX Trendline Chart
CRNX Moving Average Chart
CRNX Stock Return Map - See Patterns of Gains and Losses
CRNX Stock Returns/Purchase Dates